Navigation Links
Arena Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2013 Financial Results
Date:11/7/2013

gulatory decisions and Arena's business prospects; government and commercial reimbursement and pricing decisions; the entry into or modification or termination of collaborative arrangements; unexpected or unfavorable new data; nonclinical and clinical data is voluminous and detailed, and regulatory agencies may interpret or weigh the importance of data differently and reach different conclusions than Arena or others, request additional information, have additional recommendations or change their guidance or requirements before or after approval; data and other information related to any of Arena's research and development may not meet regulatory requirements or otherwise be sufficient for further research and development, regulatory review or approval or continued marketing; Arena's ability to obtain and defend patents; the timing, success and cost of Arena's research and development; results of clinical trials and other studies are subject to different interpretations and may not be predictive of future results; clinical trials and other studies may not proceed at the time or in the manner expected or at all; having adequate funds; and satisfactory resolution of litigation or other disagreements with others. Additional factors that could cause actual results to differ materially from those stated or implied by Arena's forward-looking statements are disclosed in Arena's filings with the Securities and Exchange Commission. These forward-looking statements represent Arena's judgment as of the time of this release. Arena disclaims any intent or obligation to update these forward-looking statements, other than as may be required under applicable law.Contact: Arena Pharmaceuticals, Inc.

Media Contact: Russo PartnersCindy McGee, Vice President,
Investor Relations & Alliance Management
cmcgee@arenapharm.com
858.453.7200, ext. 1479

David Schull, President

SOURCE Arena Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Arena Pharmaceuticals to Host Corporate Update and Financial Results Conference Call and Webcast on Thursday, November 7
2. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
3. Arena Pharmaceuticals to Present at the Bank of America Merrill Lynch Global Healthcare Conference
4. Arena Pharmaceuticals Completes Phase 1b Clinical Trial Evaluating APD811 for Pulmonary Arterial Hypertension
5. Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2013 Financial Results
6. Arena Pharmaceuticals to Host Corporate Update and Financial Results Conference Call and Webcast on Thursday, August 1
7. Arena Pharmaceuticals to Present at the 2013 Wells Fargo Securities Healthcare Conference
8. Former Semi-Pro Arena Football Player Bridged to Heart Transplant with the SynCardia Total Artificial Heart
9. Arena Pharmaceuticals to Present at the Bank of America Merrill Lynch 2013 Health Care Conference
10. BIOCOM Applauds Arena Pharmaceuticals Commitment to Innovation, Contributions to Southern California Life Science Community
11. Carena Launches 24/7 Virtual Care Delivery Service for Hospital Systems and Primary Care Clinics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... June 2, 2015 ANI Pharmaceuticals, Inc. ("ANI") ... received approval from the U.S. Food and Drug Administration ... Oxycodone Hydrochloride Oral Solution 5mg/5mL. Trailing twelve-month sales for ... three current competitors. ANI expects to begin shipping to ... , President and CEO of ANI Pharmaceuticals, stated, "This ...
(Date:6/2/2015)...  PROMETRIKA, LLC, a full-service clinical research organization ... of pharmacovigilance services for clinical trials.  PROMETRIKA has ... collection and reporting, as our service platform.  Our ... physicians, each with more than 23 years in the ... safety trends. ...
(Date:6/2/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/jrlgdj/electrophysiology ) has ... by Product {Diagnostic Catheter (Conventional, Advanced, Ultrasound)), Ablation ... Generator, ICE, X-ray)) & Indication (AF, VT, WPW) ... their offering. The global electrophysiology (EP) ... CAGR of 10.3% from 2014 to 2019 ...
Breaking Medicine Technology:ANI Pharmaceuticals Announces FDA Approval of Oxycodone Hydrochloride Oral Solution 5mg/5mL 2ANI Pharmaceuticals Announces FDA Approval of Oxycodone Hydrochloride Oral Solution 5mg/5mL 3PROMETRIKA Announces the Availability of Pharmacovigilance Services 2Global Electrophysiology Market Report 2015-2019 - Product, Ablation Catheter, Lab Devices & Indication Analysis 2Global Electrophysiology Market Report 2015-2019 - Product, Ablation Catheter, Lab Devices & Indication Analysis 3
... 21, 2011 ORTHOCON, Inc., a privately-held therapeutic device company, ... HEMA SORB Absorbable Bone Hemostat Matrix for clinical use ... is a ready-to-use, biocompatible, water resistant, and absorbable putty ... cut bone. Control of bleeding from cut bone is a ...
... NEW YORK, April 21, 2011 Reportlinker.com announces that ... catalogue: Ophthalmology DrugFutures ... complete and practical analysis of Ophthalmology Drugs packed with ... The US$14 billion global ophthalmology sector faces ...
Cached Medicine Technology:ORTHOCON® Receives CE Mark and Health Canada Medical Device License for HEMASORB® 2Reportlinker Adds Ophthalmology DrugFutures 2Reportlinker Adds Ophthalmology DrugFutures 3Reportlinker Adds Ophthalmology DrugFutures 4Reportlinker Adds Ophthalmology DrugFutures 5Reportlinker Adds Ophthalmology DrugFutures 6Reportlinker Adds Ophthalmology DrugFutures 7Reportlinker Adds Ophthalmology DrugFutures 8Reportlinker Adds Ophthalmology DrugFutures 9
(Date:6/2/2015)... Glidewell Laboratories, industry-leading provider of ... the new issue of Chairside® magazine, its restorative-dentistry-focused ... The digital edition of the latest issue, Volume ... of the dental laboratory’s magazine, can be viewed ... by visiting http://www.chairsidemagazine.com . , In the ...
(Date:6/2/2015)... TheCelebrityDresses.com, a popular online store selling celebrity inspired fashion ... cocktail dresses. The company carries more than 1000 styles ... for a wide variety of summer events like wedding ... high quality trendy special occasion dresses and ... chiffon and cotton. Their products feature a wide range ...
(Date:6/2/2015)... First Choice Emergency Room , ... the United States, named Kenneth Alan Totz, D.O.as the ... facility. , “We are pleased to announce Dr. ... said Dr. James M. Muzzarelli, Executive Medical Director of ... his undergraduate degree from St. Edwards University in Austin, ...
(Date:6/2/2015)... 2015 Thermi, formerly ThermiAesthetics, a ... successfully transitioned into its new company headquarters in ... company’s continued rapid worldwide expansion and houses the ... 25 Thermi employees, including those of the warehousing, ... “As one of the fastest growing aesthetic companies ...
(Date:6/2/2015)... (PRWEB) June 02, 2015 Join us for ... Awareness Walk in Honor of Rhonda Martin , who overcame ... have since dedicated their resources to raising awareness and funds ... to raise awareness in hopes that there will be one ... All are welcome and encouraged to join the 1st ...
Breaking Medicine News(10 mins):Health News:Glidewell Laboratories Releases New Issue of Restorative Dentistry Magazine Chairside in Print and Online 2Health News:Glidewell Laboratories Releases New Issue of Restorative Dentistry Magazine Chairside in Print and Online 3Health News:First Choice Emergency Room Announces Dr. Kenneth Alan Totz as New Medical Director of Houston – Jones Road Facility 2Health News:Thermi Moves to New Corporate Headquarters as Rapid Company Expansion Continues 2Health News:New Awareness Raising Event in Westwood, NJ to Benefit Renowned Brain Aneurysm Foundation 2
... by University of Leicester researchers has found "convincing evidence" ... potentially increase the risk of cancer development in humans. ... mass spectrometry method, the University of Leicester scientists found ... conditions. They have now published the findings in ...
... , 40+ Hospital Organization Serves Growing Non-Urban Market ... Global Med Technologies(R), Inc. ("Global Med" or the ... information technology company, today announced that its Wyndgate ... management software to a 40+ hospital healthcare system. ...
... Sponsorship of ,Ride Across America, by Phil Keoghan of CBS, The ... Well , , PITTSBURGH, June 16 Proving that health-conscious ... GNC is extremely proud to announce that GNC ... very short timeframe by sponsoring Phil Keoghan,s Ride Across America. ...
... ... announces that it is the first home health agency in California to ... utilize technology to improve health care. This home health software service ... information at the point of care, reduces costs, improves efficiency and enhances ...
... Families Seeking Affordable Meals , , ST. LOUIS, June ... to spend more on healthier versions of food, the United ... survey reveals. This is not for lack of interest: Of ... reason is financial. However, nutritious foods don,t always come with ...
... Agents from Novexel, Johnson & Johnson and Wyeth Will ... Resources , , WALTHAM, Mass., June 16 ... advisory firms for pharmaceutical and healthcare issues, finds that, ... infections drug market will increase by $1 billion from ...
Cached Medicine News:Health News:'Cannabis alters human DNA' -- new study 2Health News:Global Med Technologies(R) Licenses Transfusion Software Solution to Nationwide Healthcare System 2Health News:Global Med Technologies(R) Licenses Transfusion Software Solution to Nationwide Healthcare System 3Health News:GNC Customers Donate Over $400,000 for the National MS Society 2Health News:New Online Home Health Service Launched in California to Expand Direct Patient Care Time While Lowering Costs 2Health News:New Online Home Health Service Launched in California to Expand Direct Patient Care Time While Lowering Costs 3Health News:Finances Trigger American Reluctance to Spend More on Healthier Foods 2Health News:Despite Generic Erosion of Key Brands, the Hospital-Acquired Gram Negative Infections Drug Market Will Increase by $1 Billion from 2008 to 2018 2Health News:Despite Generic Erosion of Key Brands, the Hospital-Acquired Gram Negative Infections Drug Market Will Increase by $1 Billion from 2008 to 2018 3
... monitoring for flexible care settings., ... combine portability and measurement flexibility to ... of intermediate care environmentsat the patients ... heritage in patient monitoring, IntelliVue has ...
... information gathering and distribution power of the ... option of connecting the MPC workstations to ... The OCU is essentially a database driven ... central clearinghouse for patient information acquired from ...
... Vital Signs Monitor 300 Series enhances your ... during and after procedures. This easy to ... sign readings fast and convenient., ,The ... a noninvasive blood pressure monitor with the ...
... original Welch Allyn Vital Signs ... for clinical areas that don't ... straightforward to use, each monitor ... pressure, and optional features include ...
Medicine Products: